The company is dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in about 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier, which for at least some patients, could prove lifesaving.
As the mortality of the sepsis incidents worldwide is very high, and Greece is among the European countries with the highest levels of antibiotic resistance, MAGIRAS Diagnostics is proud of finding in Accelerate a quite distinctive partner for offering its revolutionizing technology in Microbiology, making the difference in the Health sector in Greece.